Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0NZ2D
|
|||
Drug Name |
SERCA 2a gene therapy
|
|||
Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [1] | |
Company |
Theragene Pharmaceuticals San Diego, CA
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.